Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1 249
1 166 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
AbbVie Inc
ABBV
|
$286.3775 |
+0.4%
|
$506B |
|
|
|
Amgen Inc
AMGN
|
$440.255 |
-1.6%
|
$237.6B |
|
|
|
Gilead Sciences, Inc
GILD
|
$157.075 |
-0.1%
|
$195B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$525.68 |
-1.8%
|
$133.4B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$805.43 |
-1.7%
|
$84.4B |
|
|
|
Moderna Inc
MRNA
|
$197.975 |
-2.3%
|
$78.6B |
|
|
|
CSL Ltd
CSL
|
AU$186.475 |
+1%
|
$62.7B |
|
|
|
Natera Inc
NTRA
|
$401.7101 |
+0.1%
|
$57.5B |
|
|
|
argenx SE
ARGX
|
€782.2 |
-0.2%
|
$55B |
1 161 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account